| Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy? U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ... PloS one 8 (2), e54442, 2013 | 334 | 2013 |
| The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules H Mudaliar, C Pollock, MG Komala, S Chadban, H Wu, U Panchapakesan American Journal of Physiology-Renal Physiology 305 (2), F143-F154, 2013 | 150 | 2013 |
| Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody M Singh, KJL Jackson, JJ Wang, P Schofield, MA Field, D Koppstein, ... Cell 180 (5), 878-894. e19, 2020 | 92 | 2020 |
| Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes M Gangadharan Komala, S Gross, A Zaky, C Pollock, U Panchapakesan Nephrology 21 (5), 423-431, 2016 | 77 | 2016 |
| Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice M Gangadharan Komala, S Gross, H Mudaliar, C Huang, K Pegg, ... PloS one 9 (11), e108994, 2014 | 72 | 2014 |
| Sodium glucose cotransporter 2 and the diabetic kidney MG Komala, U Panchapakesan, C Pollock, A Mather Current Opinion in Nephrology and Hypertension 22 (1), 113-119, 2013 | 67 | 2013 |
| Linagliptin limits high glucose induced conversion of latent to active TGFss through interaction with CIM6PR and limits renal tubulointerstitial fibronectin M Gangadharan Komala, S Gross, A Zaky, C Pollock, U Panchapakesan PLoS One 10 (10), e0141143, 2015 | 28 | 2015 |
| DPP4 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy U Panchapakesan, S Gross, MG Komala, K Pegg, CA Pollock J Diabetes Metab 9 (007), 2013 | 22 | 2013 |
| Prevalence and factors associated with sarcopenia in patients on maintenance dialysis in australia—a single centre, cross-sectional study M Umakanthan, JW Li, K Sud, G Duque, D Guilfoyle, K Cho, C Brown, ... Nutrients 13 (9), 3284, 2021 | 13 | 2021 |
| Investigating the regulatory process, safety, efficacy and product transparency for nutraceuticals in the USA, Europe and Australia MG Komala, SG Ong, MU Qadri, LM Elshafie, CA Pollock, S Saad Foods 12 (2), 427, 2023 | 11 | 2023 |
| Empagliflozin for the treatment of Type 2 diabetes M Gangadharan Komala, A Mather Expert Review of Clinical Pharmacology 7 (3), 271-279, 2014 | 11 | 2014 |
| Kidney adverse events associated with immune checkpoint inhibitor therapy: a systematic review and Bayesian network meta-analysis SR Trisal, G Low, F Pathan, MG Komala Clinical Journal of the American Society of Nephrology 18 (7), 843-849, 2023 | 6 | 2023 |
| Effective removal of κ-free light chains with hemodialysis using Fresenius Ultraflux® EMiC® 2 dialyser in a patient with myeloma cast nephropathy, with associated cost savings M Jayaballa, B Bose, M Gangadharan Komala, ER Fischer, J Taper, ... Blood purification 42 (2), 158-159, 2016 | 5 | 2016 |
| Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant woman S So, E Fischer, M Gangadharan Komala, B Bose Obstetric Medicine 14 (2), 105-108, 2021 | 4 | 2021 |
| Prevalence and Factors Associated with Sarcopenia in Patients on Maintenance Dialysis in Australia—A Single Centre, Cross-Sectional Study. Nutrients 2021, 13, 3284 M Umakanthan, JW Li, K Sud, G Duque, D Guilfoyle, K Cho, C Brown, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| A man with chronic lymphocytic leukemia and declining kidney function. Native kidney BK nephropathy and chronic lymphocytic leukemia/small lymphocytic lymphoma infiltration … J Collett, S Fuller, CH P'Ng, MG Komala American journal of kidney diseases: the official journal of the National …, 2016 | 1 | 2016 |
| A Case of Dulaglutide-Induced Acute Interstitial Nephritis After Many Years of Treatment With an Alternate GLP-1 Receptor Agonist MG Komala, J Renthawa Clinical Diabetes 40 (4), 508-510, 2022 | | 2022 |
| INCIDENCE AND OUTCOMES OF RENAL ADVERSE EVENTS FOLLOWING TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS J Maccan, P Kolovos, A Stevanovic, B Bose, MG Komala NEPHROLOGY 27, 29-30, 2022 | | 2022 |
| A case of minimal change disease during pregnancy–benefits of early diagnosis and use of corticosteroids PS Sagar, E Fischer, M Gangadharan Komala, B Bose Obstetric Medicine 15 (3), 198-200, 2022 | | 2022 |
| SYSTEMATIC REVIEW AND META-ANALYSIS ON CARDIOVASCULAR OUTCOMES OF PATIENTS ON DIALYSIS RECEIVING MINERALOCORTICOID RECEPTOR ANTAGONISTS E Chung, R Lin, K Negishi, MG Komala NEPHROLOGY 26, 26-26, 2021 | | 2021 |
